— Know what they know.
Not Investment Advice

PBLA OTC

Panbela Therapeutics, Inc.
1W: +0.0% 1M: +11000.0% 3M: +122.0% YTD: -15.3% 1Y: -77.8% 3Y: -100.0% 5Y: -100.0%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 62 · $53889 mcap · 5M float · 0.020% daily turnover · Short 48% of daily vol

Balance Sheet Trends

Total Assets
$12M +137.1% ▲
5Y CAGR: +44.1%
Total Liabilities
$17M +26.8% ▲
5Y CAGR: +58.9%
Shareholders Equity
-$5M +41.5% ▲
Cash & Investments
$3M +100.6% ▲
5Y CAGR: +12.9%
Total Debt
$5M -24.1% ▼
5Y CAGR: +71.5%
Net Debt
$3M -52.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$2M$9M$12M$1M$3M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$2M$9M$12M$1M$3M
Net Receivables$361K$323K$321K$49K$183K
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$443K$299K
Total Current Assets$3M$10M$12M$2M$3M
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$51K$56K$593K$3M$9M
Total Non-Current Assets$51K$56K$593K$3M$9M
Total Assets$3M$10M$13M$5M$12M
— Liabilities —
Accounts Payable$597K$554K$640K$3M$10M
Short-Term Debt$116K$0$0$2M$1M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$742K$811K$2M$3M$516K
Total Current Liabilities$2M$1M$3M$8M$12M
Long-Term Debt$0$0$0$5M$4M
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$640K$5M$4M
Total Liabilities$2M$1M$3M$13M$17M
— Equity —
Common Stock$7K$10K$13K$1K$0
Retained Earnings-$41M-$46M-$56M-$91M-$125M
Accumulated OCI$305K-$384K$133K$759K$745K
Total Stockholders Equity$1M$8M$10M-$8M-$5M
Total Liabilities & Equity$3M$10M$13M$5M$12M
— Key Metrics —
Total Debt$116K$0$0$7M$5M
Net Debt-$2M-$9M-$12M$6M$3M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms